Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.

12

Dec

Mater Research awarded $1.84 million in NHMRC funding

Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia gravis

06

Dec

New applications of drugs could reduce side effects for Myasthenia gravis patients

Dr Sam Bora has been promoted to Associate Professor at Mater Research and UQ's Faculty of Medicine.

06

Dec

Mater Researcher receives Associate Professorship

The Mater Research Awards and Young Investigator Symposium was held on Friday 29 November

04

Dec

Mater Research Awards and Young Investigator Symposium

Mater Group is proud to mark a milestone in its history, the launch of a new brand.

21

Nov

We’re Mater, and we’re better together

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

14

Nov

New test predicts breast cancer patients at risk of relapse

Mater is proud to officially welcome Professor Patrick Chauvel as Professorial Research Fellow at Mater Research.

12

Nov

Welcome Professor Patrick Chauvel

A devotion to closing the gap in maternity care for Aboriginal and Torres Strait Islander women has seen Professor Sue Kildea awarded the Health Services Research Award.

09

Nov

Closing the gap in maternity health services

Four Mater clinicians have been successful in receiving research funding from the coveted Betty McGrath Fellowship Scheme.

05

Nov

2018 Betty McGrath Fellowship Scheme recipients announced

A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.

01

Nov

App hopes to reduce stillbirths by 30 per cent

From October 2018 the new Ethics Review Manager (ERM) system will replace the Mater Research Hub to generate new applications to Mater Research Governance.

19

Oct

Ethics Review Manager System roll out - Important information for researchers

A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).

19

Oct

Mater helps bring new hope to patients with cystic fibrosis

Displaying results 1-12 (of 102)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9  >  >|